At protein levels, GLS1 and E-cadherin were reduced and there was an increase in N-cadherin levels in the tumor samples where circCOL1A1 was knocked down (Fig. 7E), suggesting a decrease in tumor aggressiveness. The gene discussed is GLS; the disease is neoplasm.